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Protein complexes are a cornerstone of many biological processes and together they form various types of molecular machinery. A
broad understanding of these protein complexes is crucial for revealing and building models of protein function and regulation.
Pancreatic cancer is a highly lethal disease which is diﬃcult to diagnose at early stage and even more diﬃcult to cure. In this
study, we applied a gradient clear native gel system combined with subsequent second-dimensional SDS-PAGE to separate protein
complexes from cell lysates of SW1990 and PANC-1 pancreatic cancer cell lines with diﬀerent degrees of diﬀerentiation. Ten
heat-shock-protein- (HSP-) associated protein complexes were separated and identiﬁed, and the diﬀerentially expressed proteins
relatedtocancerswerealsofound,suchasHSP60,proteindisulﬁde-isomeraseA4(ERp72),andtransitionalendoplasmicreticulum
ATPase (TER ATPase).
1.Introduction
Most proteins exert their functions by stable or transient in-
teractions with other proteins either as homo- or heter-
ooligomeric protein complexes [1, 2]. The diversity of
biological processes is derived from the dynamic network
of protein interactions in cell. These interactions form the
basis of the quaternary structure of multimeric proteins
and represent one of the most complex levels of structural
organization in biological molecules [3, 4]. A broad under-
standing of protein complexes and protein interactions is
crucial for revealing and building models of protein function
and regulation.
A variety of approaches were used to study protein-
protein interactions, such as tandem aﬃnity puriﬁcation
(TAP) [5], coimmunoprecipitation (co-IP) [6], yeast two-
hybridassay[7],blue/clear(colorless)nativePAGE(BN/CN-
PAGE) [8], and other gel approaches [9]. Among these
methods, BN/CN-PAGE is widely used [2] and CN-PAGE
is milder than BN-PAGE and oﬀers special advantages for
in-gel catalytic activity assays and analyses of ﬂuorescent-
labeled proteins [10, 11]. After BN/CN-PAGE, a second-di-
mensionalSDS-PAGEcanbeperformedtoseparatepolypep-
t i d e sa sc o m p o n e n t so fp r o t e i nc o m p l e x e s[ 12]. Previous
studies using BN/CN-PAGE approach mainly focused on
membrane, chloroplast, mitochondria, and plasma protein
complexes [13–18]. So far, limited studies were associated
with the protein complexes from cell lysate [19, 20].
Pancreatic cancer is a malignant neoplasm of the
pancreas. During the past four decades, the incidence of
pancreatic cancer has risen steadily [21]. The prognosis is
relatively poor with less than 5% ﬁve-year survival rate, and
complete remission is rare [22].
Heatshockproteins(HSPs)areahighlyconservedfamily
of proteins among living organisms during evolution [23].
A cell may have a variety of HSPs in cellular compartments
such as endoplasmic reticulum, mitochondria, and cytosol
[24]. HSPs have multiple functions such as proper folding
of nascent chains, protein translocation across membranes,
protein disaggregation, preservation and restructuring of the2 Journal of Biomedicine and Biotechnology
cytoskeleton, and targeting damaged proteins for degrada-
tion [24, 25]. HSPs may serve as potential molecular targets
for therapeutic intervention in the treatment of diseases,
such as cancer, Alzheimer’s, and Parkinson’s diseases [26].
The heat shock protein peptide complex-96-based vaccines
in melanoma were also tested in phase III clinical trials in
melanoma and kidney cancer [27]. In pancreatic cancer, it
was found that HSP70 and HSP90 were overexpressed [28–
30].
In this study, we applied a gradient clear native gel fol-
lowed by a second-dimensional SDS-PAGE to reveal the
HSP-associated protein complexes from the cell lysates of
SW1990 and PANC-1 pancreatic cell lines. The components
of these complexes were then identiﬁed by MALDI-MS and
MS/MS.
2.MaterialsandMethods
2.1.MaterialsandChemicals. Proteaseinhibitorcocktailtab-
lets were obtained from Roche Applied Science (Indianapo-
lis, Ind, USA). Sequencing-grade trypsin was purchased
from Roche diagnostics (Mannheim, Germany). α-cyano-4-
hydroxycinnamic acid (CHCA) was from Sigma-Aldrich (St.
Louis, Mo, USA). All other chemicals were obtained from
Merck (Darmstadt, Germany).
2.2.SamplePreparation. PANC-1andSW1990werecultured
in Dulbecco’s Modiﬁed Eagle’s medium (DMEM) and
RPMI-1640 medium, respectively, supplemented with 10%
fetal calf serum and 100U/mL penicillin/streptomycin at
37◦C and 5% CO2 in a humidiﬁed atmosphere.
AfterharvestedcellswerewashedwithPBS,thecellswere
lysed by three-cycle liquid N2/4◦Ci nl y s i sb u ﬀer (50mM
Tris-HCl, pH 7.5, 5mM MgCl2, 150mM NaCl, 0.05% NP-
40, 1mM DTT, 2×Roche protease inhibitor cocktail, 10mM
sodium ﬂuoride, and 10mM sodium pyrophosphate). The
lysate was centrifuged at 20,000xg for 60min at 4◦C. The
supernatant containing protein complexes was centrifuged
again at 10,000xg for 30min at 4◦C for at least three times to
removethelipidsinthelysate.Theproteinconcentrationwas
determined by Bradford assay using bovine serum albumin
as the standard protein.
2.3. Separation of HSP-Associated Protein Complexes. CN-
PAGE was performed based on previous protocols [31, 32].
100μg of proteins was loaded onto the gel. CN-PAGE was
performed with 4% stacking gel and 6%, 5–10% or 5–12%
separating gel with 13cm casting gel system, respectively. GE
Healthcare HMW-Native protein markers (GE Healthcare,
Uppsala, Sweden) were used. The gel was run at 4◦C until
the xylene cyanol reached the gel bottom.
2.4. Separation of the Components of HSP-Associated Protein
Complexes. For further separation in subsequent second-
dimensional SDS-PAGE, the protein complex bands or the
w h o l el a n e sf r o mC N - P A G Ew e r ec u to u ta n de q u i l i b r a t e d
for 20min in equilibrating buﬀer A containing 62.5mM
Tris-HCl pH 6.8, 2% SDS, 10% glycerol, and 1% DTT. The
bands or lanes were then dipped into equilibrating buﬀer
B supplemented with 62.5mM Tris-HCl pH 6.8, 2% SDS,
10% glycerol, and 2.5% iodoacetamide for 20min at room
temperature. The bands or lanes were washed with deionized
water followed by 12% SDS-PAGE separation. Gels were
stained with Coomassie blue G-250.
2.5. In-Gel Digestion and Protein Identiﬁcation. Protein
bands or spots from the second-dimensional SDS-PAGE
were excised and cut into small pieces. After destained, re-
duced, and alkylated, the gel pieces were dehydrated in ac-
etonitrile and covered by some volume of 12.5ng/μL trypsin
in 25mM ammonium bicarbonate for 1h at 4◦C. Protein
digestion was performed for overnight at 37◦C.
1μL of the digest was spotted onto an MTP AnchorChip
384/400 plate and dried at room temperature before the
addition of 1μLm a t r i xs o l u t i o no f1 m g / m LC H C Ai n
33% ACN/0.1% TFA. After the mixtures were completely
dried at room temperature, the AnchorChip was delivered
into autoﬂex III MALDI-TOF/TOF MS (Bruker Daltonics,
Billerica, Mass, USA). The mass spectrometer was operated
under 20kV accelerating voltage in the positive-ion reﬂec-
tron mode with the mass range of m/z 800–4000.
The monoisotopic peptide mass was generated by Flex-
analysis 3.0 (Bruker Daltonics), and the database search
was performed by Biotools 3.1 software (Bruker Daltonics)
against Swiss-Prot database using the MASCOT search
algorithm. The parameters are as follows: one missed tryptic
cleavage; taxonomy: Homo sapiens; carbamidomethylation
of cysteine as ﬁxed modiﬁcation; oxidation of methionine
andN-terminalpyroglutamylationasvariablemodiﬁcations;
mass tolerance: 0.1Da for precursor ions and 0.5Da for
product ions. Results were considered as signiﬁcant with
MASCOT score higher than 60 (P<0.05). Sequence
coverage, number of matched MS/MS, and the experimental
molecular weight based on SDS-PAGE were also used to
conﬁrm further identiﬁcation.
2.6. Protein-Protein Interaction Analysis. A protein-protein
interaction network of the proteins identiﬁed in the HSP-
associated complexes was created using STRING database
(http://string-db.org/) through inputting the Swiss-Prot ac-
cession numbers.
3. Results and Discussion
3.1. Separation of Protein Complexes by CN-PAGE. Due to
the aberrant eﬀect of hydrophobic lipids in lysate on CN-
PAGE performance, several approaches have been tried and
ﬁnally the centrifugation was chosen to remove lipids. It
should be noted that at least three-time centrifugations
were needed for complete removal of lipids. To establish
the conditions of CN-PAGE for adequately resolving protein
complexes, three separating gels were tried: 6% nongradient
(left, Figure 1(a)), 5–10% gradient (middle, Figure 1(a))
and 5–12% gradient gels (right, Figure 1(a)). As shown in
Figure 1(a),proteincomplexeswerewellseparatedon5–12%
gradient gel compared to nongradient and 5–10% gel.Journal of Biomedicine and Biotechnology 3
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Figure 1: 6% (1), 5–10% (2), and 5–12% (3) separating gels were used to separate the protein complexes from SW1990 cell lysate. M: GE
Healthcare HMW-Native protein markers; S: cell lysate of SW1990 (a). SDS-PAGE of ten protein complexes labeled with A–J from 5–12%
CN-PAGE. At least two-band combination of each complex was used to run SDS-PAGE (b).
Table 1: Identiﬁcation results of HSP-associated protein complexes.
CD E F G H I J
ORP-150 ORP-150 Alpha-actinin-4 Alpha-actinin-4 Alpha-actinin-4 Alpha-actinin-4 — —
— HSP90 HSP90 HSP90 HSP90 HSP90 HSP90 HSP90
— HSP90-beta HSP90-beta HSP90-beta HSP90-beta HSP90-beta HSP90-beta HSP90-beta
BiP BiP BiP BiP BiP BiP BiP BiP
HSP71 HSP71 HSP71 HSP71 HSP71 HSP71 — Beta-actin
ERp57 ERp57 ERp57 ERp57 ERp57 ERp57 — Gamma-actin
— ERp5 ERp5 ERp5 ERp5 ERp5 — PGAM-B
GRP-94 GRP-94 SAHase HSP60 HSP60 HSP60 HSP60 —
— NAD-ME — LDH-A — — — —
3.2. Identiﬁcation and Interaction Analysis of HSP-Associated
Protein Complexes. The protein complexes in the CN-PAGE
(right, Figure 1(a)) were individually separated by second-
dimensional SDS-PAGE (Figure 1(b)). The bands in the
SDS-PAGE were excised, digested, and identiﬁed by MALDI-
MSandMS/MS.TheidentiﬁedproteinsarelistedinTable S1
and their corresponding MASCOT score, sequence coverage,
and number of matched MS/MS are also listed in Table S1
(see Table S1 in supplementary material available online at
doi:10.1155/2011/193052). The components of each com-
plex are shown in Table 1.
T h ea p p a r e n tm a s s e so fc o m p l e xAa n dBa r ea b o u t
470kDa (right, Figure 1(a)), and the components of both
complexes were identiﬁed as HSP60 (band 1, Figure 1(b)).
A previous study showed that the HSP60 complex is a
homoheptamer with apparent mass of 420kDa in BN-PAGE
[33] .T h em a s sd i ﬀerence may be due to the fact that the CN-
PAGE migration distance depends on not only the pore size
of gradient gel but also the protein intrinsic charge and size,
while the BN-PAGE migration distance depends only on the
pore size of the gel.
For complex C, the most intensively stained protein was
identiﬁed as endoplasmin (GRP-94) (band 3, Figure 1(b)),
which is involved in the processing and transporting of
secreted proteins [34]. The other proteins are hypoxia
upregulated protein 1 (ORP-150), 78kDa glucose-regulated
protein (BiP), HSP71, and protein disulﬁde-isomerase A3
(ERp57) (Table 1). GRP-94, OPR-150, and BiP are glucose-
regulated proteins. GRP-94 and BiP are also members of
the 90 and 70kDa families of HSPs, and OPR-150 is a large
HSP70-, HSP110-like protein of the endoplasmic reticulum
[35]. HSP71 belongs to the heat shock protein 70 family.
ERp57 is a member of the protein-disulﬁde-isomerase-
(PDI-) like family, and it has been implicated in human
pathologies including cancer and Alzheimer’s disease [36].
In addition to the proteins identiﬁed in complex C, four
other proteins were identiﬁed in complex D. They are heat
shock protein HSP 90-alpha (HSP90), heat shock protein4 Journal of Biomedicine and Biotechnology
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Figure 2: Interaction analysis of proteins from the HSP-associated complexes using the STRING database. The lines represent interactions
and individual proteins are depicted as nodes. Stronger interactions are represented by thicker lines (a). The HSP-associated complexes from
this study are shown in diﬀerent ellipses. The sign of each protein complex is indicated on the edge of each ellipse (b).
HSP90-beta (HSP90-beta), protein disulﬁde isomerase P5
(ERp5), and NAD-dependent malic enzyme (NAD-ME).
HSP90 and HSP90-beta belong to the heat shock protein
90 family. HSP90 proteins play essential housekeeping func-
tions, and they are used by cancer cells to facilitate the
function of numerous oncoproteins [37, 38]. ERp5 as a
member of the protein-disulﬁde-isomerase- (PDI-)like fam-
ily was found to interact with BiP [39]. NAD-ME plays an
important role in the metabolism of glutamine for energy
production in rapidly proliferating tissues and tumors [40].Journal of Biomedicine and Biotechnology 5
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Figure 3: The protein complexes diﬀerentially expressed between SW1990; and PANC-1 cell lines were labeled by A+B, F, and K in CN-
PAGE (a). The proteins diﬀerentially expressed between two cell lines in the second-dimensional SDS-PAGE were labeled in number (b) S:
cell lysate of SW1990; P: cell lysate of PANC-1.
Table 2: Diﬀerential protein complexes and diﬀerential proteins
between SW1990 and PANC-1 cell lines.
Complex (fold change SW1990
to PANC-1) in Figure 3(a)
Spot number (protein name; fold
change SW1990 to PANC-1) in
Figure 3(b)
Complex (A+B) (1.61) 2 (HSP60; 1.85)
Complex K (1.96) 4 (ERp72; 2.11)
Complex F (found only in
SW1990) —
— 1 (TER ATPase; 1.52)
— 3 (Transglutaminase-2; found
only in PANC-1)
— 5 (Annexin A6; found only in
PANC-1)
The proteins identiﬁed in complex E are alpha-actinin-4,
HSP90, HSP90-beta, BiP, HSP71, ERp57, ERp5, and adeno-
sylhomocysteinase (SAHase). Except alpha-actinin-4 and
SAHase, the rest also were found in the complex D. Alpha-
actinin-4 regulates the actin cytoskeleton and is associated
with cell motility and cancer invasion [41]. SAHase may play
a key role in the control of methylations via regulation of the
intracellular concentration of adenosylhomocysteine [42].
The identiﬁed components of complexes of F, G, and
H are similar. Alpha-actinin-4, HSP90, HSP90-beta, BiP,
HSP71, ERp57, ERp5, and HSP60 were found in these three
complexes. It should be noted that HSP60 presents in these
three complexes, although not in the complexes of C, D, and
E. HSP60 is a molecular chaperone known to assist protein
folding in prokaryotes and in eukaryotic cell organelles. Its
roles in human cancer development are currently actively
being investigated [43].
The identiﬁed components of complex I are HSP90,
HSP90-beta, BiP, and HSP60, and the identiﬁed components
of complex J are HSP90, HSP90-beta, BiP, beta-actin, gam-
ma-actin, and phosphoglycerate mutase 1 (PGAM-B). Actin
is one of the most highly conserved proteins. The beta- and
gamma-actins co-exist in most cell types as components of
the cytoskeleton and mediators of internal cell motility [44].
PGAM-B is a key enzyme of the glycolytic pathway, which
converts 3-phosphoglycerate to 2-phosphoglycerate [45].
A network of the identiﬁed proteins in the HSP-as-
sociated complexes was obtained using the STRING software
(Figure 2(a)). In this network all proteins interact with other
proteins except SAHase. Previously, it was also found that
HSP90, HSP70, and HSP60 interacted with each other in
human cells [19, 46]. The HSP-associated complexes were
plottedinFigure 2(b).Thesecomplexeswereshownindiﬀer-
ent ellipses, respectively, indicating that HSP90, HSP90-beta,
and HSp71 are “hot” proteins in these complexes. The major
HSPs have ﬁve conserved classes: HSP100, HSP90, HSP70,
HSP60, and the small heat shock proteins (sHSPs) [47].
Each chaperone class displays relatively specialized functions
but the members of diﬀerent classes often work together
to perform their duties in the form of larger multi-protein
complexes [24, 48]. Our results indicate that, in pancreatic
cancer cells, HSP90, HSP90-beta, and HSP71 could form
many diﬀerent complexes with other proteins.
3.3. Protein Complexes Expression Diﬀerences between
SW1990 and PANC-1 Cell Lines. SW1990 and PANC-1 are
pancreatic cancer cell lines derived from pancreatic duct
with diﬀerent diﬀerentiation degrees. SW1990 is a well to
moderately diﬀerentiated cell line established from a spleen
metastasis of pancreatic duct cancer, and PANC-1 is a poorly
diﬀerentiated cell line [49, 50]. The spots with diﬀerential
expression over 1.5-folds were regarded as candidates of
diﬀerential expression, followed by MALDI-MS and MS/MS
identiﬁcations (Table S2).6 Journal of Biomedicine and Biotechnology
The expression diﬀerences of the protein complexes la-
beled by A+B, F, and K between SW1990 and PANC-1 cell
lines are shown in Figure 3(a), and diﬀerential expression
proteins labeled in number are shown in Figure 3(b).
Table 2 summarized the link between protein complexes
in Figure 3(a) and spots in Figure 3(b) and also provided
the fold changes of these complexes or individual protein
between SW1990 and PANC-1 cell lines. Compared to
PANC-1,thecomplexes(A+B)(A+Bmeansthecombination
o fc o m p l e x e sAa n dB ) ,F ,a n dKw e r eu p e x p r e s s e di n
SW1990 (Figure 3(a)). The expression trends of the com-
plexes (A+B) and K in Figure 3(a) were in accordance with
those of their components corresponding to spots 2 and 4,
respectively (Figure 3(b)). The components of the complex
F were not, however, enough in abundance to be observed
in the SDS-PAGE. Additionally, TER ATPase (spot 1,
Figure 3(b)), protein-glutamine gamma-glutamyltransferase
2 (transglutaminase-2, spot 3, Figure 3(b)), and annexin A6
(spot 5, Figure 3(b)) were obviously observed in the SDS-
PAGE.
AsshowninFigure 3(b),TERATPase(spot1)withmany
important biological functions [51] was upexpressed in
SW1990 cells, which is associated with intestinal tumori-
genesis as indicated in previous study [52]. HSP60 (spot
2, Figure 3(b)) was upexpressed in SW1990 cells. Although
the role of HSP60 in cancer has not been determined yet,
upregulation or downregulation of this chaperone has been
reported in various tumors, histopathological diagnosis and
prognosis assessment [43, 53]. HSP60 was found to be
downregulated in tumors compared with normal pancreas
tissues in the 2-DE analysis; on the contrary, the data from
immunohistochemistry showed that HSP60 was strongly
expressed in both normal acinar cells and small ducts in
normal pancreas tissues and tumor cells in all the pancreatic
ductal adenocarcinoma tissues [54].
The complex F was found only in SW1990 cell lysate
(Figure 3(a)). The diﬀerence of this HSP-associated complex
inthetwopancreaticcancercellsmaysuggesttheimportance
of HSPs in cancers as other studies reported [23, 48].
The main function of transglutaminase-2 (spot 3,
Figure 3(b)) is to catalyze the cross-linking of proteins and
conjugating of polyamines to proteins, and its expression
was elevated in most pancreatic ductal adenocarcinoma
tumors and cell lines [55]. In melanoma, transglutaminase-2
absence in the host is a favoring condition for the formation
and development of the metastasis, while the presence of
transglutaminase-2 in the tumor cells might be requested for
the development of the metastasis [56], which is consistent
with our ﬁnding of transglutaminase-2 expression only in
the poorly diﬀerentiated PANC-1 cells. Protein disulﬁde-
isomerase A4 (ERp72) (complex K, Figure 3(a);s p o t4 ,
Figure 3(b)) is another protein that was upexpressed in the
well to moderately diﬀerentiated and metastatic SW1990 cell
line.Inhepatocellularcarcinoma(HCC),theupregulationof
ERp72 was discovered not only in highly metastatic HCC cell
lines but also in highly metastatic and already metastasized
HCC patient’s sera [57]. Annexin A6 (spot 5, Figure 3(b)),
which was upregulated in PANC-1 cells, regulates the release
of Ca2+ from intracellular stores, and it displays tumor
suppressor activity via facilitating the Ca2+-dependent mem-
brane targeting of p120GAP to downregulate Ras activity
[58].
4. Conclusions
In this study, protein complexes in SW1990 and PANC-1 cell
lysates were separated and identiﬁed by 2D CN/SDS-PAGE
coupled with mass spectrometry. Ten HSP-associated com-
plexes were identiﬁed. Our study indicates that HSP90,
HSP90-beta, and HSP71 may be “core” proteins in these
complexes. The diﬀerentially expressed proteins such as
HSP60, TER ATPase, and transglutaminase-2 also were pro-
ﬁled in SW1990 and PANC-1 cells, which are cancer-related
proteins. It should be noted that the 2D CN/SDS-PAGE
coupled with mass spectrometry strategy may be a simple
and powerful tool to screen protein-protein interactions
among diﬀerent cell types and tissues.
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BN-PAGE: blue native PAGE.
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